Investments in digital therapeutics grew nearly three-fold in 2021 from 2020. Meanwhile VC dollars are also pouring into AI, psychedelics as well as faith-based for-profit apps, which attracted $175.3 million in venture funding in 2021. What’s the efficacy of these new tools and treatments?
Panel: Ben Lewis, co-founder and CEO, Limbix; Nanea Reeves, founder and CEO, Tripp; Mainul Mondal, Founder & CEO, Ellipsis Health.
Thank you to our sponsors: Advsr, a boutique M&A advisory firm; Stratpoint, an outsourced engineering firm; Scrubbed, an online bookkeeping firm; Excelerate, a community-powered business scaling networking
The webinar included representatives from ACRO Biosystems, Bristol Myers Squibb, and eNuvio
Read more...
Steven Loeb
At Invent Health, healthcare execs and investors discuss why infertility rates are so high
Read more...
Steven Loeb
The panel included Genoscience, Emmeline Ventures, Suncoast Ventures, Wisp, and GENESIS Fertility
Read more...
Steven Loeb